These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2416507)

  • 41. Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis.
    Hiraiwa A; Yamanaka K; Kwok WW; Mickelson EM; Masewicz S; Hansen JA; Radka SF; Nepom GT
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8051-5. PubMed ID: 1700425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Susceptibility to rheumatoid arthritis--the conformational equivalence hypothesis.
    Winchester R
    Clin Exp Rheumatol; 1989; 7 Suppl 3():S27-33. PubMed ID: 2514058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disease susceptibility genes and the Ia system.
    Silver J
    Rheumatol Int; 1984; 4 Suppl():25-30. PubMed ID: 6085818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-DR products are a subset of human Ia antigens.
    Makgoba MW; Fuggle SV; McMichael AJ; Morris PJ
    Nature; 1983 Feb; 301(5900):531-2. PubMed ID: 6185854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Misfolded proteins complexed with HLA class II molecules are involved in autoimmune diseases as a target for autoantibodies].
    Arase N; Arase H
    Nihon Rinsho; 2016 Feb; 74(2):359-68. PubMed ID: 26915265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for polymorphism of MB3 antigens among three HLA-D clusters associated with HLA-DR4.
    Ikeda H; Kasahara M; Ogasawara K; Takenouchi T; Okuyama T; Ishikawa N; Wakisaka A; Kikuchi Y; Aizawa M
    Immunogenetics; 1984; 19(5):381-90. PubMed ID: 6202628
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope.
    Seremetis S; Cuttner J; Winchester R
    J Clin Invest; 1985 Oct; 76(4):1391-7. PubMed ID: 2414320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human 'Ia' antigen populations defined by monoclonal antibodies.
    Sparrow RL; McKenzie IF
    J Immunogenet; 1983 Jun; 10(3):179-89. PubMed ID: 6192177
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for the separate molecular expression of four distinct polymorphic Ia epitopes on cells of DR4 homozygous individuals.
    Toguchi T; Burmester G; Nunez-Roldan A; Gregersen P; Seremetis S; Lee S; Szer I; Winchester R
    Hum Immunol; 1984 Jun; 10(2):69-81. PubMed ID: 6203881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticollagen antibodies and immune response gene products in rheumatoid arthritis.
    Collier DH; Kerwar SS; Garovoy MR; Fye KH; Stobo JD
    Arthritis Rheum; 1984 Nov; 27(11):1201-9. PubMed ID: 6437412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MHC and autoimmune diseases: susceptibility to rheumatoid arthritis associated with a hydrophobic strip of alpha helix encoded by several MHC alleles.
    Winchester R; Dwyer E
    Immunol Ser; 1991; 55():203-19. PubMed ID: 1954286
    [No Abstract]   [Full Text] [Related]  

  • 52. Hybrid HLA-DC antigens provide molecular evidence for gene trans-complementation.
    Charron DJ; Lotteau V; Turmel P
    Nature; 1984 Nov 8-14; 312(5990):157-9. PubMed ID: 6209579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The molecular basis of susceptibility to rheumatoid arthritis.
    Winchester R
    Adv Immunol; 1994; 56():389-466. PubMed ID: 7521116
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetics and expression of mouse Ia antigens.
    Mengle-Gaw L; McDevitt HO
    Annu Rev Immunol; 1985; 3():367-96. PubMed ID: 3933531
    [No Abstract]   [Full Text] [Related]  

  • 55. Human Ia beta chains and the invariant chain share a common antigenic determinant.
    Finn OJ; Stackhouse CJ; Metzgar RS
    J Exp Med; 1983 Oct; 158(4):1344-9. PubMed ID: 6194245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemistry of MHC class II molecules.
    Giles RC; Capra JD
    Tissue Antigens; 1985 Feb; 25(2):57-68. PubMed ID: 3887644
    [No Abstract]   [Full Text] [Related]  

  • 57. Microfingerprinting analysis of human Ia molecules favours a three loci model.
    Sorrentino R; Corte G; Calabi F; Tanigaki N; Tosi R
    Mol Immunol; 1983 Mar; 20(3):333-43. PubMed ID: 6191204
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA-DR antigens on lymphoid cells differ from those on myeloid cells.
    Torok-Storb B; Nepom GT; Nepom BS; Hansen JA
    Nature; 1983 Oct 6-12; 305(5934):541-3. PubMed ID: 6194439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Rheumatoid arthritis and HLA class II antigens].
    Bardin T
    Presse Med; 1989 Jun; 18(24):1189-90. PubMed ID: 2472632
    [No Abstract]   [Full Text] [Related]  

  • 60. Genes associated with rheumatoid arthritis and mild inflammatory arthritis. II. Association of HLA with complement C3 and immunoglobulin Gm allotypes.
    Puttick AH; Briggs DC; Welsh KI; Williamson EA; Jacoby RK; Jones VE
    Ann Rheum Dis; 1990 Apr; 49(4):225-8. PubMed ID: 2111124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.